[144] Lifeway Foods, Inc. SEC Filing
Rhea-AI Filing Summary
Form 144 notice for Lifeway Foods, Inc. (LWAY) shows a proposed sale of 6,357 shares of common stock through Citigroup Global Markets Inc. on 09/23/2025 on NASDAQ with an aggregate market value of $168,653.75. The filing reports that the securities were acquired on 05/19/2023 by purchase from Ludmila Smolyansky and that 3,197,975 shares were acquired on that date for cash. The total number of shares outstanding is listed as 15,226,520. Several issuer-identifying fields (issuer name, address, and the specific name of the person for whose account the securities are to be sold) are not provided in the visible content of this form.
Positive
- Clear acquisition history: the filing states the securities were purchased on 05/19/2023 from Ludmila Smolyansky and paid in cash.
- Brokered sale through a major dealer: trade to be executed via Citigroup Global Markets Inc., indicating standard market handling.
- Small sale relative to outstanding shares: 6,357 shares versus 15,226,520 shares outstanding, implying limited immediate supply impact.
Negative
- Missing issuer/person details: the issuer name, issuer address, and the specific "person for whose account" fields are not present in the provided content, reducing transparency.
- Aggregate market value notable: the transaction value of $168,653.75 is disclosed but its materiality to holders or company is unclear from this form alone.
- No disclosure of a trading plan: the visible excerpt does not include an explicit statement of a Rule 10b5-1 trading plan adoption date, if any.
Insights
TL;DR: Routine Rule 144 sale filed; proposed sale is a small volume relative to reported acquisition and outstanding shares.
The filing documents a notice of proposed resale under Rule 144 for 6,357 common shares valued at $168,653.75 to be executed through Citigroup Global Markets Inc. The acquisition history shows a purchase of 3,197,975 shares on 05/19/2023 from Ludmila Smolyansky paid in cash, which provides clear provenance and satisfies the ‘‘how acquired’’ disclosure. The sale amount is small relative to the stated outstanding shares (15,226,520), suggesting limited immediate dilution or market pressure based on the numbers disclosed. The form omits several issuer-identifying details in the visible content, which limits deeper assessment of potential insider status or insider selling patterns.
TL;DR: Filing is a standard compliance disclosure; missing issuer/person fields reduce transparency for governance review.
The notice meets Rule 144 structure by stating broker, shares, acquisition date, seller name, payment method, and planned sale date. From a governance perspective, the presence of the original seller's name and the cash purchase history is helpful. However, the lack of an explicit named person for whose account the securities will be sold and missing issuer contact/address information in the provided content impedes a full governance assessment regarding insider status, potential 10b5-1 plans, or aggregation with other related-party sales. No recent sales in the prior three months are reported on this form.